Retrograde Ascending Dissection: Intraluminal Aortic Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Home/Ascending Aortic Dissection/

View on ClinicalTrials.gov

Recruiting

Back to Ascending Aortic Dissection trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Shanghai Jiao Tong University Medical School Affiliated Ruijing Hospital, Shanghai, Shanghai Municipality

Key details

Sponsor

Ruijin Hospital

Enrollment target

~149 participants

Started

January 2026

Primary completion

December 2029

Age range

65 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Retrograde Ascending Dissection: Intraluminal Aortic Therapy — Stella